| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SCICLONE PHARMACEUTICALS INC COM | 1,082,532 | 14,138,000 | 14.50% | ||
| 2 | Viveve Medical, Inc | 2,599,711 | 10,659,000 | 10.93% | ||
| 3 | AEGERION PHARMACEUTICALS INC | 17,300,000 | 9,861,000 | 10.11% | PRN | |
| 4 | VANDA PHARMACEUTICALS INC COM | 811,563 | 9,081,000 | 9.31% | ||
| 5 | TOBIRA THERAPEUTICS INC | 637,567 | 8,008,000 | 8.21% | ||
| 6 | PAIN THERAPEUTICS INC | 2,837,878 | 6,215,000 | 6.37% | ||
| 7 | QLT INC | 3,779,274 | 5,367,000 | 5.50% | ||
| 8 | SAGENT PHARMACEUTICALS INC | 356,307 | 5,337,000 | 5.47% | ||
| 9 | VERICEL CORP | 2,250,000 | 5,063,000 | 5.19% | ||
| 10 | CUTERA INC COM | 438,000 | 4,910,000 | 5.03% | ||
| 11 | SOCIETAL CDMO INC | 428,670 | 3,408,000 | 3.49% | ||
| 12 | ALERE INC | 75,000 | 3,126,000 | 3.20% | ||
| 13 | SUCAMPO PHARMACEUTICALS INC | 213,860 | 2,346,000 | 2.41% | ||
| 14 | PACIRA BIOSCIENCES INC | 52,157 | 1,759,000 | 1.80% | ||
| 15 | PERNIX THERAPEUTICS HOLDINGS INC | 6,000,000 | 1,380,000 | 1.41% | PRN | |
| 16 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 128,005 | 1,375,000 | 1.41% | ||
| 17 | BIOSPECIFICS TECHNOLOGIES CORP COM | 30,000 | 1,198,000 | 1.23% | ||
| 18 | Enanta Pharmaceuticals, Inc. | 52,616 | 1,160,000 | 1.19% | ||
| 19 | DERMA SCIENCES INC COM PAR .01 | 283,306 | 1,116,000 | 1.14% | ||
| 20 | VERACYTE INC | 186,926 | 940,000 | 0.96% | ||
| 21 | CUMBERLAND PHARMACEUTICALS I COM | 128,798 | 580,000 | 0.59% | ||
| 22 | AVIRAGEN THERAPEUTICS INC | 294,269 | 412,000 | 0.42% | ||
| 23 | DURECT CORP | 80,160 | 98,000 | 0.10% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001140361-16-075782, filed 2016.08.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
